Team:BIOSINT Mexico/finacial

From 2012e.igem.org

(Difference between revisions)
 
(5 intermediate revisions not shown)
Line 99: Line 99:
               <li class="last"><a href="https://2012e.igem.org/wiki/index.php/Team:BIOSINT_Mexico/Attributions">Sponsors</a></li>
               <li class="last"><a href="https://2012e.igem.org/wiki/index.php/Team:BIOSINT_Mexico/Attributions">Sponsors</a></li>
               </ul>
               </ul>
 +
<a class="igem" href="https://igem.org/Main_Page"><img src="http://www.persoft.mx/biosint/images/ICL_iGEM_Logo.png" alt="" /></a>
           </nav>
           </nav>
           <h1><a href="https://2012e.igem.org/wiki/index.php/Team:BIOSINT_Mexico"><img src="http://www.persoft.mx/biosint/images/logo.png" alt=""></a></h1>  
           <h1><a href="https://2012e.igem.org/wiki/index.php/Team:BIOSINT_Mexico"><img src="http://www.persoft.mx/biosint/images/logo.png" alt=""></a></h1>  
Line 127: Line 128:
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Initial investment.</p>
+
                                 <p class="clr-1"><strong>Initial investment.</strong></p>
                             </div>
                             </div>
-
                             <p>Vivamus hendrerit mauris ut dui. gravida ut viverra lectus tincidunt. Cras mattis tempor eros nec tristique. Sed sed felis arcu, vel vehicula augue. Maecenas faucibus sagittis cursus. </p>
+
                             <p>Pre-operative expenses: The business incubator of the ITESM Campus Querétaro and the Parque Tecnológico have helped in the creation of Kuxtal Biotech, these institutions provided personal assessment as part of a pre-incubation process that have a total cost of 446.71 USD. </br></br>
 +
Financial Plan: The required initial investment is $725,732.14 USD, to obtain this value, the following was considered:</br>
 +
• $644,095.14 USD related to fixed assets, this includes all the laboratory equipment, and office equipment.</br>
 +
• $6,561.54 USD related to deferred assets, this includes publicity, rent, installations, and preoperative expenses.</br>
 +
• $75,075.46 USD related to circulating assets, this includes the necessary capital to be able to work for six months.</br></br>
 +
</p>
                         </div>
                         </div>
               </div>
               </div>
Line 136: Line 142:
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Financial indicators.</p>
+
                                 <p class="clr-1"><strong>Financial indicators.</strong></p>
                             </div>
                             </div>
-
                             <p>Vivamus hendrerit mauris ut dui. gravida ut viverra lectus tincidunt. Cras mattis tempor eros nec tristique. Sed sed felis arcu, vel vehicula augue. Maecenas faucibus sagittis cursus. </p>
+
                             <p>• The operation budget will be $63,114.69 USD, this includes salary wages for personal in charge of production and indirect expenses of production.</br>
 +
• The administration budget will be $67,230.77 USD, this includes salary wages for administrative staff and the expenses related to this department.</br>
 +
• The travel expenses budget for the salesmen staff will be $6,153.85USD.</br></br>
 +
The equilibrium point was calculated as follows: </br>
 +
(Total fixed costs)/(Sale price-Variable costs)</br>
 +
Considering this, Kuxtal Biotech needs to sale 38,758.49 oligonucleotides with 20 bp of length to finance the expenses but without any earnings.
 +
 
 +
</br></br>
 +
 
 +
 
 +
<div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Balancep.png"/></div>
 +
</p>
                         </div>
                         </div>
Line 146: Line 163:
                     <div class="p-border">
                     <div class="p-border">
                             <div class="wrap">
                             <div class="wrap">
-
                                 <p class="clr-1">Project evaluation.</p>
+
                                 <p class="clr-1"><strong>Project evaluation.</strong></p>
                             </div>
                             </div>
-
                             <p>Vivamus hendrerit mauris ut dui. gravida ut viverra lectus tincidunt. Cras mattis tempor eros nec tristique. Sed sed felis arcu, vel vehicula augue. Maecenas faucibus sagittis cursus. </p>
+
                             <p><div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Finanzas.png"/></div></p>
                         </div>
                         </div>

Latest revision as of 02:17, 28 October 2012

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
The Chihuahua is the world’s smallest dog.
Its name comes from a Mexican state.

Financial Plan

Initial investment.

Pre-operative expenses: The business incubator of the ITESM Campus Querétaro and the Parque Tecnológico have helped in the creation of Kuxtal Biotech, these institutions provided personal assessment as part of a pre-incubation process that have a total cost of 446.71 USD.

Financial Plan: The required initial investment is $725,732.14 USD, to obtain this value, the following was considered:
• $644,095.14 USD related to fixed assets, this includes all the laboratory equipment, and office equipment.
• $6,561.54 USD related to deferred assets, this includes publicity, rent, installations, and preoperative expenses.
• $75,075.46 USD related to circulating assets, this includes the necessary capital to be able to work for six months.

Financial indicators.

• The operation budget will be $63,114.69 USD, this includes salary wages for personal in charge of production and indirect expenses of production.
• The administration budget will be $67,230.77 USD, this includes salary wages for administrative staff and the expenses related to this department.
• The travel expenses budget for the salesmen staff will be $6,153.85USD.

The equilibrium point was calculated as follows:
(Total fixed costs)/(Sale price-Variable costs)
Considering this, Kuxtal Biotech needs to sale 38,758.49 oligonucleotides with 20 bp of length to finance the expenses but without any earnings.

Project evaluation.